Search

everythinglearnresearchcommunity

for

Search:↓

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

LHX2, with other markers, can identify hair placodes in rats.

The BMP/Smads pathway and Id2 gene control hair follicle stem cells, affecting their rest and growth phases.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

NBCCS and BFHS might be the same syndrome, helping better identify and manage cases.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

The CUBIC protocol allows detailed 3D visualization of proteins in mouse skin biopsies.

Somatic BHD mutations are rare in Japanese renal tumors.

B cells can both help and hinder the body's defense against melanoma.

BTNL2 helps protect hair follicles from immune attacks.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

Sebaceous glands are often preserved and PPARy expression is constant in some cases of Central Centrifugal Cicatricial Alopecia.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Keratins 8 and 14 can help identify and diagnose benign skin tumors.

Basal cell carcinomas likely originate from hair follicle cells or stem cells.

Some hair proteins are specific to hair, while others are also found in skin cells.

Bcl-2 affects hair growth and pigmentation by controlling cell death.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

Apocrine type cutaneous mixed tumors often resemble hair follicles, sebaceous glands, and apocrine glands.

Raman micro-spectroscopy can help distinguish basal cell carcinoma from hair follicles in skin tissue.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

EBV infection increases a specific keratin variant in carcinoma cells, possibly affecting cell structure and cancer progression.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.